Targeted randomization dose optimization trials enable fractional dosing of scarce drugs by Philip S. Boonstra, Alex Tabarrok, Garth W. Strohbehn

Get full text

Targeted randomization dose optimization trials enable fractional dosing of scarce drugs. by Philip S Boonstra, Alex Tabarrok, Garth W Strohbehn

Get full text

TP63 isoform expression is linked with distinct clinical outcomes in cancer by Armand Bankhead, III, Thomas McMaster, Yin Wang, Philip S. Boonstra, Phillip L. Palmbos

Get full text

Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels by Peter G. Hawkins, Philip S. Boonstra, Stephen T. Hobson, James A. Hayman, Randall K. Ten Haken, Martha M. Matuszak, Paul Stanton, Gregory P. Kalemkerian, Theodore S. Lawrence, Matthew J. Schipper, Feng-Ming (Spring) Kong, Shruti Jolly

Get full text

Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy by Daniel R. Owen, BS, Yilun Sun, PhD, Philip S. Boonstra, PhD, Matthew McFarlane, MD, PhD, Benjamin L. Viglianti, MD, PhD, James M. Balter, PhD, Issam El Naqa, PhD, Matthew J. Schipper, PhD, Caitlin A. Schonewolf, MD, Randall K. Ten Haken, PhD, Feng-Ming S. Kong, MD, PhD, Shruti Jolly, MD, Martha M. Matuszak, PhD

Get full text